Burning Rock Biotech Announces Delisting Of American Depositary Shares From LSE, Effective September 18, 2024
Portfolio Pulse from Benzinga Newsdesk
Burning Rock Biotech has announced the delisting of its American Depositary Shares (ADS) from the London Stock Exchange (LSE), effective September 18, 2024.

August 19, 2024 | 6:37 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Burning Rock Biotech will delist its American Depositary Shares from the London Stock Exchange, effective September 18, 2024. This move may impact the liquidity and trading volume of BNR shares.
The delisting of BNR's ADS from the LSE could reduce the liquidity and trading volume of its shares, potentially leading to short-term downward pressure on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100